Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.


INTRODUCTION Rituximab (RTX), a chimeric mouse anti-human CD20 monoclonal antibody, is indicated for the treatment of patients with non-Hodgkin's lymphoma, chronic lymphocytic leukemia, granulomatosis with polyangiitis and microscopic polyangiitis, and rheumatoid arthritis, but nowadays it is increasingly used for the treatment of many other immune-mediated… (More)
DOI: 10.1517/14712598.2014.912273